Dual light-responsive cellulose nanofibril-based in situ hydrogel for drug-resistant bacteria infected wound healing

Carbohydr Polym. 2022 Dec 1:297:120042. doi: 10.1016/j.carbpol.2022.120042. Epub 2022 Sep 1.

Abstract

In situ hydrogels with rapid hemostasis and antibacterial activity have received considerable attention in the field of wound healing. Herein, a white light and NIR dual light-responsive cellulose nanofibril (CNF)-based in situ hydrogel wound dressing is tailored by using white light-responsive CNF and endogenous antibacterial CNF as the skeleton, Prussian blue nanoparticles, Pluronic® F127 and hydroxypropyl methyl cellulose as the NIR, temperature-responsive switch and binder, respectively. The dressing exhibits rapid hemostasis properties in rat liver injury model with low blood loss of 286.4 mg and short hemostasis time of 63 s. Meanwhile, the antibacterial activity of the dressing with white and NIR irradiation against Escherichia coli, Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) is higher than 99.9 %. Interestingly, the dressing with biocompatibility can promote MRSA infection wound healing and can be removed on demand without secondary injury to skin. Therefore, it has promising applications for first-aid hemostasis and wound healing.

Keywords: Cellulose nanofibril; Hemostasis; In situ hydrogels; Sol-gel-sol transition; Wound dressing.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacteria
  • Cellulose / pharmacology
  • Escherichia coli
  • Hydrogels / pharmacology
  • Methicillin-Resistant Staphylococcus aureus*
  • Methylcellulose
  • Poloxamer
  • Rats
  • Wound Healing
  • Wound Infection* / drug therapy

Substances

  • Anti-Bacterial Agents
  • Hydrogels
  • Poloxamer
  • Cellulose
  • Methylcellulose